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Resumen 
Antecedentes: el polimorfismo de la apolipoproteína E (ApoE) es un determinante genético de los niveles de lípidos y lipoproteínas y el riesgo 
de enfermedad coronaria. 
Objetivo: para evaluar el impacto del alelo ApoE2 en los niveles de lípidos plasmáticos y la influencia de una dieta hipocalórica sana más una 
actividad física controlada en el perfil lipídico, se realizó un estudio en una cohorte de sujetos sanos con sobrepeso y obesidad (índice de masa 
corporal entre 25-34,9 kg·m-2). 
Métodos: ciento ochenta participantes (96 mujeres), de 18-50 años participaron en una intervención de pérdida de peso de 22 semanas basada 
en el mismo tratamiento dietético y diferentes programas de ejercicios controlados. Todos los sujetos siguieron una dieta hipocalórica (consumo 
de energía entre 25-30% inferior que el gasto energético total diario). Se obtuvieron muestras de sangre para las mediciones de lípidos al inicio 
y al final del estudio. 
Resultados: después de la intervención, los hombres del grupo E2 mostraron las mayores disminuciones en los valores de lipoproteína de baja 
densidad (LDL), triglicéridos (TG) y colesterol total (TC) (p = 0,039; p = 0,001; p = 0,001). Para las lipoproteínas de alta densidad (HDL), el grupo 
E2 presentó diferencias significativas en comparación con E4 en los valores previos (p = 0,020) y postintervención (p = 0,024). 
Conclusión: nuestros resultados muestran grandes cambios en los hombres que portan ApoE2, principalmente en las concentraciones de TG y 
TC después del tratamiento con dieta hipocalórica y ejercicio controlado. Por lo tanto, la adición de entrenamiento supervisado a la intervención 
nutricional parece ser una buena alternativa para el refuerzo del efecto del tratamiento.
Abstract 
Background: apolipoprotein E (ApoE) polymorphism is a genetic determinant of lipid and lipoprotein levels and the risk for coronary heart disease. 
Objective: to evaluate the impact of ApoE2 allele in lipid plasma levels and the influence of a healthy hypocaloric diet plus a controlled physical 
activity on the lipid profile, we performed a study in a cohort of overweight and obese healthy subjects (Body Mass Index (BMI) between 25 and 
34.9 kg·m-2). 
Methods: one hundred eighty participants (96 women), aged 18-50 years participated in a 22 weeks weight loss intervention based on same 
dietary treatment and different controlled exercise programs. All subjects followed a hypocaloric diet (25-30% less energy intake than the daily 
energy expenditure). Blood samples were obtained for lipids measurements at the beginning and end of the study. 
Results: after intervention, men of the E2 group showed the greatest decreases in low-density lipoprotein (LDL), triglycerides (TG) and total 
cholesterol (TC) values (p = 0.039; p = 0.001; p = 0.001; respectively). For high-density lipoprotein (HDL), E2 group had significant differences 
compared with E4 at pre- (p = 0.020) and post-intervention values (p = 0.024). 
Conclusion: our results show great changes in men carrying ApoE2, mainly in TG and TC concentrations after treatment with hypocaloric diet 
and controlled exercise. Therefore, adding supervised training to nutritional intervention seems to be a good alternative for the reinforcement of 
the effect of the treatment.
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INTRODUCTION
Atherosclerosis is a multifactorial disease involving environ-
mental and genetic factors and their interactions (1). The lipopro-
tein concentrations are modulated by different apolipoproteins, 
mainly by the multifunctional apolipoprotein E (ApoE), that plays 
a key role in the metabolism of cholesterol and triglycerides by 
binding to hepatic ApoE receptor or LDLR in the liver to help medi-
ate clearance of chylomicrons and very low-density lipoproteins 
from the plasma (1-3). So, ApoE plays a crucial role in transport 
and redistribution of lipids in peripheral tissues such as brain 
peripheral nerves, and arterial wall (4). The phenotype of severe 
hyperlipidemia and spontaneous development of atherosclerosis 
in mice lacking ApoE clearly demonstrates the central role of ApoE 
in mammalian lipid metabolism (5,6).
The ApoE gene locus is polymorphic with 3 common alleles, 
designated as ApoE2, ApoE3 and ApoE4. The corresponding 
protein isoform for each allele has different affinity for the cel-
lular apolipoprotein receptor (7). Hence, the presence of at least 
one ApoE4 allele is associated with lower plasma ApoE (8) and 
increased plasma cholesterol, LDL cholesterol, and ApoB levels 
(2). The presence of at least one copy of the ApoE2 allele has 
been associated with higher plasma ApoE (8) and lower plasma 
cholesterol, LDL cholesterol, and ApoB levels (2) when compared 
with ApoE3 homozygotes. The ApoE2 allele is also associated 
with lower risk of coronary artery disease (9), except in 5-10% 
of ApoE2 homozygotes who develop type III hyperlipoproteinemia 
and premature atherosclerosis (10). Under an obesogenic environ-
ment (sedentarism, hypercaloric and cholesterol-enriched diets), 
the presence of the ApoE4 allele is associated with a significant 
risk of coronary artery disease (9), when compared with ApoE3 
homozygotes. Low-cholesterol diets normalize lipid profile and 
minimize cardiovascular risk in subjects with at least one ApoE4 
allele. In addition, clinical trials and longitudinal studies indicate 
that after supervised exercise carriers of the ApoE2 allele and 
homozygotes for the ApoE3 allele have greater improvements in 
plasma lipoprotein lipid than ApoE4 carriers (11-13). However, the 
impact of a strict hypocaloric and equilibrated diet plus controlled 
physical activity program in ApoE2 and ApoE4 carriers it is less 
established.
Therefore, in order to investigate the impact of ApoE2 allele in 
triglycerides plasma levels, and the influence of a healthy hypo-
caloric-diet plus a controlled physical activity program on lipid 
profile, we performed a study with overweight and obese healthy 




The present RCT (ClinicalTrials.gov ID: NCT01116856) was 
conducted from January, 2010, through June, 2011, and fol-
lowed the ethical guidelines of the Declaration of Helsinki. The 
Institutional Review Board of the Hospital Universitario La Paz 
(PI-643) reviewed and approved the study design and research 
protocol. Details of the study’s theoretical rationale, protocol, and 
intervention are described elsewhere (14).
PARTICIPANTS
Participants were sought via advertisements in newspapers and 
on the radio, internet and TV. The sample population consisted of 
180 subjects (96 women and 84 men, weight: 80.44 ± 10.1, 96.40 
± 9.43 kg; height: 1.63 ± 0.06, 1.76 ± 0.7 m; BMI: 30.29 ± 1.22, 
age; 38.01 ± 7.8, 38.3 ± 8.01 years) overweight (n = 84, 48 
women and 36 men; BMI 25-29.9 kg/m2) and obese participants 
(n = 96, 48 women and 48 men; BMI 30-34.9 kg/m2). All subjects 
were healthy, normoglycaemic, non-smokers, but led sedentary 
lifestyles. All female subjects had regular menstrual cycles. The 
exclusion criteria covered all physical and psychological diseases 
that may have precluded the performance of the requested strength 
or endurance training, and the taking of any medication known to 
influence physical performance or the interpretation of the results. 
Subjects with a background of systematic strength or endurance 
training (moderate to high intensity training more than once a week) 
in the year before the study started were also excluded. Before 
starting, all participants signed an institutionally approved document 
of informed consent. 
PROCEDURES
A 6-months diet and exercise-based intervention, focusing on 
a behavior change. Participants entered into the study in two 
waves, one of overweight participants and the other of obese 
participants. Each wave was split into four randomly assigned 
groups, stratified by age and sex: strength group (S), endurance 
group (E), combined strength and endurance group (SE) and the 
control group, who follow the physical activity recommendations. 
The measurements took place in the first week (pre-intervention 
values) for all participants before starting and after 22 weeks of 
intervention, in week 24 (post-intervention values).
Before the intervention started, physical activity was assessed 
by a SenseWear Pro3 Armband™ accelerometer (Body Media, 
Pittsburgh, PA). Daily energy expenditure was calculated using 
the Body Media propriety algorithm (Interview Research Software 
Version 6.0). In addition, they were required to report the kind, 
duration, and intensity of any physical activity and the amount of 
any food undertaken during the intervention period, through a 
personal diary, to ensure compliance with the recommendations 
given.
At the beginning of the intervention, the negative energy bal-
ance was calculated taking into account the daily energy expen-
diture, and an estimated 3-day food record, in order to decrease 
the energy intake of the diet by a 25-30% during the intervention.
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EXERCISE INTERVENTION
All exercise training groups (Strength, Endurance and Com-
bined-SE groups) followed an individualized training program, 
which consisted on three times per week exercise sessions 
during 22 weeks, carefully supervised by certified personal train-
ers. Details of the different protocols developed by the groups 
are described elsewhere (14). An adherence to exercise of 80% 
was required.
CONTROL GROUP
Participants from the control group followed the dietary inter-
vention and respected the recommendations about physical activi-
ty from the American College of Sport Medicine (ACSM) (15). Thus, 
the C subjects were advised to undertake at least 200-300 min 
of moderate-intensity physical activity per week (30-60 min on 
most, if not all, days of the week).
DIET INTERVENTION
All groups underwent an individualized and hypocaloric diet 
(between 1,200 and 3,000 kcal). The diet implied a 25% reduc-
tion from the total daily energy expenditure (TDEE) (16) measured 
using SenseWear Pro Armband™ data. Macronutrient distribution 
consisted of 29-34% of energy from fat, 12-18% from protein, 
and 50-55% from carbohydrates, according to recommenda-
tions (17). A dietician interviewed each participant at baseline, 
3 months, and 6 months and reviewed a 3-day food record diary. 




All blood samples were taken after 12 h fast between 7:00 
and 9:00 a.m. at baseline and post-training intervention (week 
1 and week 24). All post-training samples were obtained 72 
hours after the last training day to avoid acute effects of training 
on blood lipids. All blood samples were drawn from the ante-
cubital vein and handled according to standardized laboratory 
practice at Hospital Universitario La Paz. Serum biochemicals 
total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, 
high-density lipoprotein (HDL) cholesterol, and TG (19) were 
determined using enzymatic methods with Olympus reagents by 
automated spectrophotometry performed on Olympus AU 5400 
(Olympus Diagnostica, Hamburg, Germany). Menstrual cycle was 
controlled by diary to define the follicular and luteal phases when 
blood samples were taken (20).
Genotyping
Genomic DNA was extracted from peripheral blood using a QIAamp 
DNA Blood Mini kit (QIAGEN, Hilden, Germany). The ApoE genotypes 
for the ApoE3, ApoE4 (rs7412) and ApoE2 (rs429358) alleles were 
determined by polymerase chain reaction (PCR) and allele-specific 
restriction digestion of the amplified products with the restriction 
enzyme HhaI (21). Samples were analyzed in Metabolism, Genetics 
and Nutrition Research Group of the Universidad de Cantabria-IDIVAL. 
Subjects were typed at the ApoE locus as previously described (22). 
To analyse the association of the ApoE phenotype with lipid and apoli-
poprotein responses and lipoprotein fractions, subjects were grouped 
as E2 carriers (E2: E3/E2 subjects), E3 homozygotes (E3/E3 subjects) 
and E4 carriers (E4: E4/E4 and E4/E3 subjects). A single subject with 
ApoE4/2 phenotype was not included in the study sample.
Body composition
Body composition was assessed by Dual-energy X-ray Absorp-
tiometry DXA (GE Lunar Prodigy; GE Healthcare, Madison, WI, GE 
Encore 2002, version 6.10.029 software) and was used to mea-
sure total body fat (%). Anthropometric measures included height 
(stadiometer SECA; range 80-200 cm), body mass (BC-420MA. 
Bio Lógica. Tecnología Médica S.L.) and body mass index (BMI) 
calculated as [body weight (kg)/(height (m))2].
Physical fitness
Peak oxygen uptake test (VO
2peak
) was measured using the mod-
ified Bruce protocol used elsewhere with overweight and obese 
population (23,24). The test was conducted on an H/P/COSMOS 
3P 4.0 computerised treadmill (H/P/Cosmos Sports & Medical, 
Nussdorf-Traunstein, Germany). The volume and composition of 
expired gas measure were measured using a Jaeger Oxycon Pro 
gas analyser (Erich Jaeger, Viasys Healthcare, Germany) and con-
tinuous 12-lead electrocardiographic monitoring. The exercise test 
was maintained until exhaustion. Peak oxygen uptake (VO
2peak) 
was 
taken to be the mean of the three largest measurements. 
STATISTICAL ANALYSES 
SPSS version 15.0 for Windows was used for statistical analy-
ses (SPSS Inc., Chicago, Illinois, USA). Standard statistical meth-
ods were used for the calculation of the means and standard 
deviation (SD). 
Three-way analysis of variance (ANOVA) for repeated measures 
was used to determine any differences between men and women 
and differences in baseline values and post-training values in 
each ApoE group assessed (E2, E3 and E4). Multivariate analysis 
of variance (MANOVA) was used to compare ApoE group and sex 
in differences in baseline and post-training values. 
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Bonferroni’s post-hoc test was employed to locate specific dif-
ferences. The delta percentage was calculated through the stan-
dard formula: change (%) = [(post-test score − pre-test score)/
pre-test score] × 100. The significance level was set at α = 0.05.
RESULTS
Due to alterations in data collection final analysed completers 
were n = 173 (94 women and 79 men). The ApoE2, ApoE3, and 
ApoE4 alleles had frequencies of 0.04, 0.88, and 0.08, respec-
tively. The distribution of the ApoE genotypes is E2/E3 7.5%; E2/
E4 0.6%; E3/E3 76.4%; E3/E4 14.9%; and E4/E4 0.6%; and 
did not differ between males and females (p = 0.961). All the 
genotype frequencies of the analysed gene polymorphism were in 
agreement with the Hardy-Weinberg equilibrium (chi-square test 
= 1.60; p = 0.660). The genotype groups were initially similar in 
terms of age, body weight and composition, VO
2max
, and plasma 
lipoprotein lipid profiles. After the intervention, body composition 
and VO
2peak
 did not differ significantly among groups (Table I).
BLOOD LIPIDS AND LIPOPROTEINS
Table II shows the changes in plasma lipid and lipoprotein con-
centrations in three APOE (APOE gene) groups before and after 
the intervention period. At baseline, E2 group had a more adverse 
lipid profile for the atherogenic variables. Men of the E2 group had 
significantly higher TG levels compared to E3 and E4 groups (E3 p 
= 0.001; E4 p = 0.018). However, for HDL, E2 group had healthy 
values with significant differences with E3 (p = 0.010) and E4 (p = 
0.020) groups. After intervention, the men of the E2 group achieved 
the greatest decrease in both TG (p = 0.001) and TC concentrations 
(p = 0.001). Furthermore, the E2 group maintained the HDL levels, 
being significantly higher than the E4 men (p = 0.024).
On the other hand, men of the E3 group decreased LDL, TG and 
TC concentrations (p = 0.001; p = 0.012; p = 0.001; respective-
ly), and increased HDL levels (p = 0.013) after the intervention.
In contrast, E4 men obtained a reduction only in LDL (p = 
0.007) and TC (p = 0.006) levels.
In the group of women who participated in our study no signif-
icant differences were observed among genotype groups either 
baseline or the post-training values. Only women of the E3 group 
showed a slight improvement in the lipid profile with a significant 
decrease in the levels of TC (p = 0.008) after the intervention, 
although their HDL levels also decreased (p = 0.048).
Figure 1 shows the percentage of change in blood lipid profile 
by ApoE and gender groups. There were significant differences 
between E2 men and E3 men for TG and TC concentrations (p = 
0.050; p = 0.022, respectively).
DISCUSSION
The main finding of the present study was that the presence of 
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Several studies have demonstrated an association between the 
ApoE phenotype and lipid levels. This work, to our knowledge, is 
the first well controlled clinical trial (14) to examine the effects 
of ApoE genotype on the response to a weight loss program with 
diet combining exercise. 
Based on the review of Hagberg et al. (12) low-fat diet inter-
ventions tend to reduce plasma lipoprotein levels more in ApoE4 
carriers than in either ApoE2 carriers or ApoE3 homozygotes. 
Interventions with dietary fat content similarly to our study showed 
the greatest TC and LDL responses in ApoE4 carriers (25-27). 
However, in our results we observed that E4 group had low 
influence on the change in lipid profile after a treatment com-
bining diet and exercise. These differences could be due to the 
pre-intervention healthy status (no clinical relevant dyslipemia) 
of participants required in our intervention, as well as the type of 
diet (well balanced and hypocaloric maintaining 29-34% energy 
intake of lipids).
On the other hand, different studies (28,29) showed evidence 
that plasma lipoprotein-lipid responses to exercise training might 
be influenced by the ApoE genotype. These authors reported that 
physical activity levels did not affect plasma lipoprotein-lipid levels 
in E4 men. Furthermore, and in accordance with our results, the 
E2 men group showed the greatest responses after the exercise 
intervention program (13,28,29). According to our results, Hag-
berg et al. found that middle-aged and older ApoE2 genotype men 
had larger overall plasma lipoprotein-lipid profile improvements 
with prolonged endurance exercise training than ApoE3 homozy-
gotes and E4 carriers men (22). Therefore, the best treatment to 
improve lipid profile for the E2 carriers seems to be an exercise 
program, since diet intervention studies showed no improvements 
in lipid profile for E2 carriers (25,30).
The most favourable response in all lipid profile variables for 
men in the E2 group (decrease LDL, TG and TC and increase HDL) 
can be due to the increase in physical activity through our inter-
vention, since regular exercise is known to increase the amount 
of lipoprotein lipase (LPL) in adipose and muscle tissue. This may 
reduce TG concentrations adding the decreased fat intake. How-
ever, this better response of the E2 group could be due to the 
higher initial levels, which can be considered as high values (31). 





























































































































































































































































































































































































































































































































































































































































































































































Percentage of change (%) in blood lipid profile by ApoE group and gender (aSig-
nificantly different from E2 carriers. bSignificantly different from E3 homozygotes).
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with impaired clearance of remnant particles containing ApoE2, 
presumably due to defective receptor recognition of ApoE2 con-
taining particles (32). The work of Taimela et al. (13) found a 
stronger effect of physical activity on TC in men carrying the E2 
allele. The authors of these study (13,22) concluded that plasma 
lipoprotein profiles of E2 individuals appear to be especially affect-
ed by increased physical fitness.
In E3 men, our results showed a greater increase in HDL. This 
may be related to increased adherence to the HDL particle. HDL is 
cholesterol enriched in part by the LPL (lipoprotein lipase) mediat-
ed transfer of cholesterol from VLDL, and this is one of the postu-
lated mechanisms by which exercise training increases HDL (33).
On the other hand, LDL decreased significantly to values con-
sidered as no atherogenic for all ApoE groups without differences 
among groups in men. These results are consistent with other 
interventions to improve dyslipidemia (33,34). This result suggests 
that our intervention is appropriate to reduce cardiovascular risk 
even in men with borderline atherogenic values (31). On the other 
hand, for the women of our study we observed no significant 
differences between baseline and final lipid profile levels except 
for TC in E3 group. The work by Leon et al. (28) reported more 
favourable changes in TG concentrations for E4/E4 women.
In our study, pre-treatment lipids levels for the ApoE genotypes 
showed values close to non-atherogenic concentrations especially 
in women. This was due to the inclusion criteria of our study, since 
all the participants were healthy overweight and obese people. How-
ever, it is important to emphasize that the BMI of the participants 
increased the risk of having metabolism lipid alterations. A point of 
interest of the present study was to include the randomized-con-
trolled design, the long-supervised training period and the lifestyle 
changes. Another strength was that it is the first, which combines 
diet and exercise and includes normoglycemic and borderline or no 
atherogenic lipid profile according to the guidelines published by the 
expert panel report (31), young to middle-aged men and women. 
Furthermore, our participants achieved healthy or non-atherogenic 
values. In contrast, a limitation of this study is that sample size could 
be too small to detect significant differences among ApoE groups. 
Another limitation could be that not all the participants followed the 
same exercise program although the different protocols had the 
same volume and intensity and they did not show significant differ-
ences between intervention groups for lipid profile changes (35,36).
Summarizing, this article explains what type of training is the 
most appropriate according to the polymorphism of ApoE that the 
subject has. In conclusion, we observed greater improvements in 
lipid profile in men carrying the ApoE2 allele after a highly-controlled 
diet and exercise program, mainly due to decreases in TG and TC 
concentrations. Future research is required in order to confirm this 
finding and, if confirmed, to define the mechanism for this effect.
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